Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11634419 Dimethyl amino azetidine amides as JAK inhibitors

Patent 11634419 was granted and assigned to Theravance on April, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Cameron Smith0

Corbin Thompson0

Daniel D. Long0

Date of Patent

April 25, 2023

0

Patent Application Number

172487170

Date Filed

February 4, 2021

0

Patent Citations

US Patent 10392386 JAK inhibitors containing a 4-membered heterocyclic amide

0

US Patent 10406148 Methods of treatment using a JAK inhibitor compound

0

US Patent 10493077 Fused imidazo-piperidine JAK inhibitor compound

0

US Patent 10519153 Fused imidazo-piperidine JAK inhibitors

0

US Patent 10526330 JAK kinase inhibitor compounds for treatment of respiratory disease

0

US Patent 10548886 Methods of treatment using a JAK inhibitor compound

0

US Patent 10550118 JAK inhibitors containing a 4-membered heterocyclic amide

0

US Patent 10836763 5 to 7 membered heterocyclic amides as JAK inhibitors

0

...

Patent Citations Received

US Patent 12122773 Crystalline hydrate of a JAK inhibitor compound

0

Patent Primary Examiner

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11634419 Dimethyl amino azetidine amides as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool